IVL vs ELCA for Stent Underexpantsion (IVL-ELCA DRAGON)

NCT ID: NCT06276114

Last Updated: 2024-02-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

121 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-01

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The IVL- ELCA DRAGON Registry is a multicenter study that enrolled consecutive patients with stent underexpansion treated with IVL ora ELCA in high-volume PCI centers.

The primary efficacy endpoint was device success (technical success with a final stent expansion ≥ 80%). Thirty days device-oriented composite endpoint (DOCE: cardiac death, target lesion revascularization, or target vessel myocardial infarction) was the secondary endpoint.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Calcification Intravascular Lithotripsy Excimer Laser-coronary Atherectomy Stent Restenosis Stent Occlusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Consecutive patients with stent underexpantsion treated with IVL

Stent Underexpansion

Intervention Type DEVICE

Stent underexpansion was diagnosed as stent expansion of \<80% assessed with intravascular imaging.

Consecutive patients with stent underexpantsion treated ELCA

Stent Underexpansion

Intervention Type DEVICE

Stent underexpansion was diagnosed as stent expansion of \<80% assessed with intravascular imaging.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stent Underexpansion

Stent underexpansion was diagnosed as stent expansion of \<80% assessed with intravascular imaging.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Stent underexpansion as stent expansion of \<80% assessed with intravascular imaging (minimum in-stent lumen area divided by average reference lumen area x100%).
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Silesia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wojciech Wańha

MD, PhD, Prof. Ass.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Unit of Structural Interventional Cardiology, Department of Clinical and Experimental Medicine, Careggi University Hospital

Florence, , Italy

Site Status

Fabrizio D'Ascenzo

Turin, , Italy

Site Status

Department of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital

Bialystok, , Poland

Site Status

First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland

Gdansk, , Poland

Site Status

Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland

Katowice, , Poland

Site Status

Jacek Legutko

Krakow, , Poland

Site Status

Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland

Krakow, , Poland

Site Status

1st Military Hospital in Lublin, Lublin, Poland

Lubin, , Poland

Site Status

Department of Cardiology, Copper Health Centre (MCZ)

Lubin, , Poland

Site Status

Clinical Department of Interventional Cardiology, Medical University of Lublin

Lublin, , Poland

Site Status

Department of Cardiology, University Hospital, Institute of Medical Sciences

Opole, , Poland

Site Status

Department of Cardiology, Poznan University of Medical Sciences

Poznan, , Poland

Site Status

Department of Cardiology, The Ministry of Internal Affairs and Administration Hospital, Rzeszow

Rzeszów, , Poland

Site Status

1st Department of Cardiology, Medical University of Warsaw

Warsaw, , Poland

Site Status

Department of Cardiology and Internal Diseases, Military Institute of Medicine

Warsaw, , Poland

Site Status

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland

Warsaw, , Poland

Site Status

Department of Invasive Cardiology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration

Warsaw, , Poland

Site Status

Department of Invasive Cardiology, Wejherowo

Wejherowo, , Poland

Site Status

Centre for Heart Disease, University Hospital Wroclaw Department of Heart Disease, Wroclaw Medical University

Wroclaw, , Poland

Site Status

Third Department of Cardiology, Medical University of Katowice

Zabrze, , Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy Poland

References

Explore related publications, articles, or registry entries linked to this study.

Wanha W, Tomaniak M, Wanczura P, Bil J, Januszek R, Wolny R, Opolski MP, Kuzma L, Janas A, Figatowski T, Gasior P, Milewski M, Roleder-Dylewska M, Lewicki L, Kulczycki J, Wlodarczak A, Tomasiewicz B, Iwanczyk S, Sacha J, Koltowski L, Dziarmaga M, Jaguszewski M, Kralisz P, Olajossy B, Sobieszek G, Dyrbus K, Lebek M, Smolka G, Reczuch K, Gil RJ, Dobrzycki S, Kwiatkowski P, Rogala M, Gasior M, Ochala A, Kochman J, Witkowski A, Lesiak M, D'Ascenzo F, Bartus S, Wojakowski W. Intravascular Lithotripsy for the Treatment of Stent Underexpansion: The Multicenter IVL-DRAGON Registry. J Clin Med. 2022 Mar 23;11(7):1779. doi: 10.3390/jcm11071779.

Reference Type BACKGROUND
PMID: 35407387 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Shockwave IVL + DCB
NCT05625997 RECRUITING